top of page
Our Vision
Pioneering the Future of Cancer Treatment with Effective, Durable and Accessible T and NK Cell Therapy
Our Mission
Develop transformative platform technology to generate next-generation T/NK cell therapies with superior potency and durability, driving long-lasting clinical responses
Our company
Sakura Bio is an innovative biotech company aiming to transform the future of cell therapy with effective, durable, and accessible T and NK cell treatments.
Our core technology, T-Boost, enhances the potency, persistence, and resistance of reprogrammed T and NK cells against the tumor microenvironment, addressing critical limitations of current CAR-T and other cell therapies.
PUBLICATION
Publication
2025 September
Cell & Gene Therapy International
Boston 2025.
bottom of page